Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?

Summary by The Motley Fool
Key PointsShares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly.Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their drug pipelines.10 stocks we like better than Teva Pharmaceutical Industries › Shares of Teva Pharmaceutical Industries (NYSE: TEVA) rallied after it reported earnings on Nov. 5. The stock is now higher by a whopping 45% in roughly a month. …

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Sunday, December 14, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal